Hvad er åbningstiderne?

Mandag 09:00 - 16:00 Tirsdag 09:00 - 16:00 Onsdag 09:00 - 16:00 Torsdag 09:00 - 16:00 Fredag 09:00 - 16:00

Biogenity

Hjem
Danmark
Aalborg
Biogenity

Rutevejledning Website

Biogenity is a data-driven biotechnology company.

13/10/2026

💊 𝗣𝗿𝗼𝘁𝗲𝗼𝗺𝗲 𝗱𝘆𝗻𝗮𝗺𝗶𝗰𝘀 𝗽𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴 𝗶𝗻 𝗱𝗿𝘂𝗴 𝗺𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺 𝘀𝘁𝘂𝗱𝗶𝗲𝘀
In drug development, changes in protein abundance alone rarely explain how a compound acts. Distinguishing between proteins that are already present and those that are newly produced provides a more informative view of drug mechanism and specificity.

Proteome dynamics profiling separates mature and nascent proteins, enabling assessment of which proteins are stabilized or degraded after drug treatment and which exhibit altered production rates. This added resolution supports early evaluation of on-target and off-target effects that may be missed by standard global proteomics.

At Biogenity, this approach is used when understanding how a drug perturbs the proteome is as important as identifying which proteins change.

💬 Investigating drug mechanism or specificity at the protein level? Let’s discuss whether proteome dynamics profiling fits your study.

🔗 https://biogenity.com/proteomics-drug-development

09/10/2026

📄 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝘀𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗔𝗰𝘂𝘁𝗲 𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗲𝗳𝗳𝗲𝗰𝘁𝘀 𝗼𝗳 𝗕𝗮𝗰𝗶𝗹𝗹𝘂𝘀 𝘀𝘂𝗯𝘁𝗶𝗹𝗶𝘀 𝗗𝗘𝟭𝟭𝟭 (𝟮𝟬𝟮𝟮)
Looking back at this randomized, double-blinded, placebo-controlled human study published in Beneficial Microbes - scientific journal, the researchers set out to explore what happens in the human small intestine just hours after probiotic ingestion - a biological window that is rarely accessible.

Using ileostomy samples collected four hours after oral intake of Bacillus subtilis DE111, the study combined metabolomics, proteomics, and metagenomics to capture early molecular responses. The results revealed rapid changes in metabolic profiles, immune-related protein expression, and lipid-associated pathways, while microbiome composition remained largely stable aside from the presence of the probiotic itself.

Biogenity provided proteomics data acquisition, processing, and analysis, supporting protein-level insights into immune regulation and lipid metabolism observed shortly after ingestion.

Looking back, studies like this highlight how integrated omics approaches can reveal immediate physiological effects that would otherwise remain hidden.

🔗 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: https://doi.org/10.3920/BM2022.0081

30/09/2026

📆 𝗕𝗶𝗼𝗴𝗲𝗻𝗶𝘁𝘆 𝗮𝘁 𝘁𝗵𝗲 𝟳𝘁𝗵 𝗗𝗦𝗘𝗩 𝗔𝗻𝗻𝘂𝗮𝗹 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝟮𝟬𝟮𝟲
This Thursday, October 1st, Paul Manna from Biogenity will be at the 7th Annual Symposium of the Danish Society for Extracellular Vesicles (DSEV) at the University of Copenhagen.

From EV characterisation to biomarker discovery, the programme touches many of the areas we work in every day. As a CRO for proteomics, transcriptomics and metabolomics, we support researchers from study design to data delivery.

If you are working with extracellular vesicles and want to talk about your next study, find Paul during the breaks or message him on LinkedIn to arrange a time. We are looking forward to attending this year's EV Symposium.

24/09/2026

𝗟𝗶𝗽𝗶𝗱 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘀𝗺 𝗶𝗻 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗱𝗶𝘀𝗲𝗮𝘀𝗲
Lipids play multiple roles in biology: energy storage, membrane structure, and signaling. Changes in lipid composition often reflect shifts in metabolism, inflammation, or physiological state long before they are visible at the phenotypic level.

Biogenity’s lipid metabolism services focus on quantitative profiling across a broad range of lipid classes, including fatty acids, phospholipids, bile acids, and lipid mediators. This allows researchers to study lipid homeostasis, metabolic adaptation, and lipid-driven signaling in a structured, reproducible way.

The service is well-suited for projects where lipid composition is central to the biological question rather than a secondary readout.

𝗪𝗼𝗿𝗸𝗶𝗻𝗴 𝗼𝗻 𝗮 𝗽𝗿𝗼𝗷𝗲𝗰𝘁 𝘄𝗵𝗲𝗿𝗲 𝗹𝗶𝗽𝗶𝗱 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘀𝗺 𝗶𝘀 𝗮 𝗸𝗲𝘆 𝗱𝗿𝗶𝘃𝗲𝗿? Let’s discuss which lipid panels fit your study.

🔗 https://biogenity.com/metabolomics/lipid-metabolism-services

22/09/2026

🧬 𝗢𝗹𝗶𝗻𝗸 𝗣𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀 𝗶𝗻 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗱𝗮𝘁𝗮 𝗶𝗻𝘁𝗲𝗿𝗽𝗿𝗲𝘁𝗮𝘁𝗶𝗼𝗻
High-quality protein measurements are only valuable if they can be translated into biological insight. Statistical analysis, pathway context, and domain expertise are required to extract meaning from proteomic data.

At Biogenity, Olink proteomics projects include bioinformatic analysis and biological contextualization, supporting interpretation at both protein and pathway levels.

Generating protein data, but unsure how to interpret it biologically? Let’s discuss analysis and interpretation approaches.

🔗 https://biogenity.com/olink-proteomics

17/09/2026

𝗠𝗲𝘁𝗮𝗽𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀: 𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻, 𝗡𝗼𝘁 𝗝𝘂𝘀𝘁 𝗖𝗼𝗺𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻
Species lists only tell you who's present. Metaproteomics shows what they're doing, mapping protein expression across microbial communities to reveal real functional activity, not just taxonomy.

At Biogenity, we run the full workflow end-to-end:
‣ Optimised sample preparation for complex microbial and host-microbiome specimens, from gut and soil to bioreactors and fermentation
‣ High-resolution LC-MS/MS for deep, reproducible proteome coverage
‣ Expert data analysis and biological interpretation, so you get publication-ready results tied directly to your research questions

Whether you're studying a gut microbiome, a bioreactor, or a fermentation process, we help you understand how it actually responds, not just what's living in it.

Ready to see what your samples can really tell you? Book a free consultation with our team.

&d

16/09/2026

💬 𝗔 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻 𝘄𝗲 𝗼𝗳𝘁𝗲𝗻 𝗴𝗲𝘁 𝗮𝘁 𝗕𝗶𝗼𝗴𝗲𝗻𝗶𝘁𝘆
“𝘋𝘰 𝘺𝘰𝘶 𝘰𝘧𝘧𝘦𝘳 𝘢𝘤𝘢𝘥𝘦𝘮𝘪𝘤 𝘥𝘪𝘴𝘤𝘰𝘶𝘯𝘵𝘴?”

Yes, we offer academic discounts for eligible researchers and institutions.

If you’re affiliated with a university or research organization, discounts can be applied once academic status is confirmed. This is typically discussed early in the project dialogue, together with study scope and budget considerations.

Our aim is to make high-quality omics accessible, while still ensuring the study is thoughtfully designed and supported from the very beginning.

👉 𝘎𝘰𝘵 𝘢 𝘲𝘶𝘦𝘴𝘵𝘪𝘰𝘯 𝘧𝘰𝘳 𝘰𝘶𝘳 𝘘&𝘈 𝘴𝘦𝘳𝘪𝘦𝘴? 𝘓𝘦𝘢𝘷𝘦 𝘪𝘵 𝘪𝘯 𝘵𝘩𝘦 𝘤𝘰𝘮𝘮𝘦𝘯𝘵𝘴 𝘢𝘯𝘥 𝘸𝘦 𝘮𝘢𝘺 𝘤𝘰𝘷𝘦𝘳 𝘪𝘵.

10/09/2026

🌐 𝗨𝗻𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 𝗮𝘀 𝗮 𝗰𝗼𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁 𝘁𝗼 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻
Untargeted metabolomics is most informative when combined with targeted analysis. While targeted panels provide quantitative precision, untargeted screening adds breadth by revealing additional metabolites and pathway activity that were not originally considered.

At Biogenity, untargeted analysis is often integrated with Amino Acid and Energy Metabolism workflows and can be extended with lipid, bile acid, or short-chain fatty acid panels. This combination supports both hypothesis testing and discovery within the same study.

The result is a more complete metabolic picture, supporting interpretation across nutrition, metabolism, microbiome interactions, and systems biology.

👉 Planning a metabolomics study and unsure how much discovery depth you need? Let’s discuss targeted and untargeted strategies together.

🔗 https://biogenity.com/metabolomics/untargeted-metabolomics

02/09/2026

📄 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝘀𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗧𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗽𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀 𝘀𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗞𝗹𝗼𝘁𝗵𝗼 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 (𝟮𝟬𝟮𝟭)
In 2021, a study published in Scientific Reports investigated expression of the longevity-associated protein α-Klotho in the naked mole rat, a species known for its exceptional lifespan.

Because no specific antibodies exist for detecting Klotho in this model, the researchers applied targeted proteomics using Parallel Reaction Monitoring (PRM) to measure Klotho protein expression in kidney and liver tissue.

At Biogenity, we performed the PRM-based proteomics analysis, using high-resolution mass spectrometry to detect Klotho-derived peptides in complex tissue samples.

We enjoy looking back at studies like this, where targeted mass spectrometry enables protein-level measurements when conventional approaches are not available.

🔗 https://doi.org/10.1038/s41598-021-94972-1

01/09/2026

📚 𝗛𝗼𝘄 𝗮 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗼𝗯𝘀𝗲𝗿𝘃𝗮𝘁𝗶𝗼𝗻 𝗯𝗲𝗰𝗮𝗺𝗲 𝗕𝗶𝗼𝗴𝗲𝗻𝗶𝘁𝘆
What started as an observation at a research conference in Dublin has grown into a company working with clients worldwide.

Our co-founder and CEO, Kenneth Kastaniegaard, first saw the opportunity while completing his PhD: a huge amount of existing research data was going underused, while researchers kept running costly new experiments to get answers that were often already there. That insight became the foundation for Biogenity.

Aalborg University recently featured our story - from the early idea to how we work today, helping researchers, hospitals, and biotech and pharma companies turn biological data into insights that move their research forward.

𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗵𝗲𝗿𝗲: https://www.aau.dk/a-remark-in-dublin-sowed-the-seed-for-biogenity-n172399

Adresse

Niels Jerns Vej 10
Aalborg
9220

Åbningstider

Mandag	09:00 - 16:00
Tirsdag	09:00 - 16:00
Onsdag	09:00 - 16:00
Torsdag	09:00 - 16:00
Fredag	09:00 - 16:00

Website

https://biogenity.com/

Underretninger

Bliv den første, der får besked: Vi sender dig en e-mail, når Biogenity offentliggør nyheder og tilbud. Din e-mailadresse bliver ikke brugt til andre formål, og du kan til enhver tid afmelde dig.

Vil du placere din virksomhed øverst på virksomhed-listen i Aalborg?